PT-141 in Orlando
Bremelanotide, also known by the development name PT-141 and marketed as Vyleesi®, is a prescription medication FDA-approved for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD involves persistently or recurrently low sexual desire that causes marked distress or interpersonal difficulty and is not primarily caused by another medical or psychiatric condition, relationship problem, or medication or substance.
Vyleesi® is a single-use subcutaneous injection administered in the abdomen or thigh, as needed, at least 45 minutes before anticipated sexual activity. Vyleesi® is not FDA-indicated for postmenopausal women, men, or enhancement of sexual performance.
How It Works
Bremelanotide is a medication that acts on certain receptors in the brain. Although the exact way it improves HSDD is not fully understood, it may help regulate the brain signals involved in sexual desire.
Potential Benefits
In the trials behind the FDA-approved version, some premenopausal women reported:
Increased sexual desire
Less distress about their low desire
Evidence in men and in postmenopausal women is thinner, and responses vary widely from person to person.
Who May Be an Appropriate Candidate
Low desire usually has a cause. Your provider looks for it first because several common causes may respond better to something other than PT-141. Hormone levels, thyroid function, sleep, stress, depression, and side effects from medications you already take are all on that list.
PT-141 is not an option if you have
Uncontrolled high blood pressure
Known heart disease
How It Is Administered
Route
This is done through an injection under the skin, usually in the abdomen or thigh.
When
Vyleesi® can be administered typically at least 45 minutes before anticipated sexual activity.
Who Does It
You can do it at home, after our team shows you how.
How Often It May Be Used
Only as needed. The FDA-approved version caps use at one dose in 24 hours and eight doses a month. Your provider sets your limits.
Safety Considerations
Compounded PT-141 is not FDA-approved, which means that the FDA has not reviewed it for safety, effectiveness, or quality, and a prescription does not change that.
Reported side effects include:
Nausea, which was common in trials
Flushing and headache
Soreness at the injection site
A short-lived rise in blood pressure after a dose
Patches of darker skin with repeated use, which may not fully fade
Tell your provider about every medication you take, especially anything for blood pressure. If something feels wrong, call us instead of adjusting your dose.
Talk With Our Clinical Team
Whether PT-141 suits you depends on what’s behind the change, and that is what the evaluation is for. We need baseline labs on file before prescribing any peptide. However, lab results are one input among several and are not the sole deciding factor.
The Discovery Consultation is free, and it doesn’t commit you to treatment.